AOCI at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s AOCI?
- Denali Therapeutics Inc. (DNLI) reported AOCI of -$682K in Q1 2026.
- How has Denali Therapeutics Inc.'s AOCI changed year-over-year?
- Denali Therapeutics Inc.'s AOCI decreased by 133.5% year-over-year, from $2.04M to -$682K.
- What is the long-term trend for Denali Therapeutics Inc.'s AOCI?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s AOCI has grown at a 22.7% compound annual growth rate (CAGR), from -$245K to $682K.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.